Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 16 Sept 2024 for Mereo BioPharma Group plc, €31k.
Filing timeline
BuySaleAlexandra Hughes-Wilson
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
Alexandra Hughes-Wilson: trading record in brief
Alexandra Hughes-Wilson discloses dealings in Mereo BioPharma Group plc to SEC (Form 4). Between 22 May 2024 and 13 September 2024, the trades on record add up to 16 filings.
No open-market purchase appears, only 8 sales worth €958k. Other entries cover 2 share grants and 6 option exercises.
On 16 September 2024 came the latest disclosure, an open-market sale for €62k in Mereo BioPharma Group plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Alexandra Hughes-Wilson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
7,769 shares@ US$4.472716.8% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-106968:0
40,000 shares0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-106413:0
10,134 shares@ US$3.693918.7% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-078462:0
60,000 shares0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-077479:0
93,333 shares@ US$1.4064.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-064274:0
5 of 5 declarations
